DaVita Inc. (DVA)

Why DaVita HealthCare (DVA) Outpaced the Stock Market Today

DaVita: After A 25% Drop, The Buyback Machine Is Cheap Again

Here's Why You Should Retain DaVita Stock in Your Portfolio for Now

DaVita Activates Emergency Response Efforts Ahead of Hurricane Isaias, Urges Kidney Patients to Prepare Early

3 Berkshire Hathaway Holdings to Buy While They Sit at Least 15% Below Their Highs

DaVita HealthCare (DVA) Laps the Stock Market: Here's Why

This Warren Buffett Stock Is Up 58%. History Says This Is What Happens Next.

DaVita HealthCare (DVA) Registers a Bigger Fall Than the Market: Important Facts to Note

3 Surging Stocks That Don't Need the AI Boom to Keep Winning

DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors

Warren Buffett, Donald Trump Bet on Same 17 Stocks — Some Might Surprise You

A Look at DaVita Inc (DVA) After 4.3% Gain -- GF Value $195.67 vs Price $189.32

Here's Why You Should Retain DaVita Stock in Your Portfolio for Now

Why Is DaVita HealthCare (DVA) Down 4.9% Since Last Earnings Report?

Do Options Traders Know Something About DaVita Stock We Don't?

4 Outpatient & Home Healthcare Stocks in Focus Amid Industry Tailwinds

Warren Buffett and Greg Abel Quietly Hold a Bigger Percentage of This Company Than Any Other in Berkshire's Portfolio (Hint: It's Not Apple or American Express)

DVA & Humana Expand Value-Based Care for Kidney Disease Patients

Alebund Pharmaceuticals Announces 2026 Interim Results

DaVita Announces New Value-Based Partnership with Humana to Expand Care for Patients with Chronic Kidney Disease